Ω76: A designed antimicrobial peptide to combat carbapenem- and tigecycline-resistant Acinetobacter baumannii

Drug resistance is a public health concern that threatens to undermine decades of medical progress. ESKAPE pathogens cause most nosocomial infections, and are frequently resistant to carbapenem antibiotics, usually leaving tigecycline and colistin as the last treatment options. However, increasing t...

詳細記述

保存先:
書誌詳細
出版年:Sci Adv
主要な著者: Nagarajan, Deepesh, Roy, Natasha, Kulkarni, Omkar, Nanajkar, Neha, Datey, Akshay, Ravichandran, Sathyabaarathi, Thakur, Chandrani, T., Sandeep, Aprameya, Indumathi V., Sarma, Siddhartha P., Chakravortty, Dipshikha, Chandra, Nagasuma
フォーマット: Artigo
言語:Inglês
出版事項: American Association for the Advancement of Science 2019
主題:
Research Articles
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6656545/
https://ncbi.nlm.nih.gov/pubmed/31355341
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aax1946
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料